TIP logo

TIP

Thrombin Inhibition Preoperatively in Early Breast Cancer

TIP

Thrombin Inhibition Preoperatively in Early Breast Cancer
Funding NIHR Clinician Scientist Award
Portfolio Cancer
Interventions Medicine
Randomised Yes
Status Recruiting
Start Date 26-Apr-2016

To determine whether preoperative oral Factor Xa inhibitor (Rivaroxaban) in oestrogen receptor negative early breast cancer patients results in inhibition of tumour proliferation markers as determined by a reduction in tumour Ki67 from baseline (pretreatment) to post treatment (at time of surgical excision).